Skip to main content

THE TUMOR SUPPRESSOR NDRG2 DISRUPTS THE ONCOGENICITY OF THE CYTOPLASMIC PRMT5 IN ATL LEUKEMIA

Research Authors
BEID SHANAB
KAZUHIRO MORISHITA
AHMED Y. NASSAR3
MOHAMMED N. ISMAIL
MOHAMMED SALAH1
Research Department
Research Journal
Assiut Veterinary Medical Journa
Research Member
Research Publisher
NULL
Research Rank
2
Research Vol
Vol. 63 No. 153
Research Website
NULL
Research Year
2017
Research_Pages
145-156
Research Abstract

ABSTRACT
Adult T-cell leukemia (ATL) is an oncogenic disease derived from the HTLV-1-infected T cells and there is no effective therapy known yet. We previously reported that down-regulation of N-myc downstream-regulated
gene-2 (NDRG2) expression by DNA Methylation and genetic deletion presents one of the most common
alterations in adult T-cell leukemia (ATL) and other various kinds of cancers. A stress-induced NDRG2
suppresses important signaling pathways (PI3K and NF-κB) through the de-phosphorylation of PTEN and NIK
as a PP2A recruiter. In this manuscript, we identified protein arginine methyltransferase 5 (PRMT5) as a
NDRG2/PP2A binding partner. A NDRG2/PP2A complex down-regulated arginine methyltransferase activity of
PRMT5 through de-phosphorylation of the serine and threonine residues and changing its co-localization to the nucleus of ATL cell lines increasing the histone arginine methylation; however, PRMT5 was highly
phosphorylated and localized in cytoplasm in NDRG2-deficient ATL.